1. The study of association between iNKT cells in recipient with aGVHD after allogeneic HSCT.”
2. The study of correlation between regulatory T cells in PBSC grafts with aGVHD after allogeneic HSCT in patients with blood malignancy referred to taleghani hospital in 2016.”
3. The study of association between soluble CD226 levels with aGvHD after allogeneic HSCT
4. Study of association between CD4+/CD8+ count with aGVHD after allogenic hematopoietic SCT in patients with blood malignancy
5. Evaluation of ST2 as a biomarker for aGvHD
6. Evaluation of Elafin as a prognostic biomarker for skin aGVHD
7. Evaluation of tim-3 as a biomarker for GI-GVHD
8. evaluation of CCL8 and CXCL10 as biomarkers of aGVHD.”
9. Evaluation of viral PCR positivity in stool before allogenic HSCT as a predictor marker for aGI-GVHD.
10. Evaluation of 3-IS as an affordable and quick marker for prediction of microbiota disruption in GI-GvHD
11. Evaluation of Reg3-alpha as a discriminator marker between GVHD and non GVHD causes of diarrhea
12. Evaluation of Intestinal Blautia as predictive factor of GI-GVHD
13. Evaluation of TH1/TH2 ratio in donor and recipient as a prognostic factor of GVHD after allo HSCT
14. Evaluation of serum profile of cytokines as potential biomarkers for prediction/prognosis of acute GVHD following allogeneic HSCT
15. Evaluation of homing molecules, CLA and CCR4 and CCR10 as a prognostic biomarker of acute GvHD in patients referring to BMT center of Taleghani Hospital in 2016
16. Evaluation of α4β7 integrin and CCR5 as prognostic biomarkers in GI-GvHD
17. Study of association between AAT and aGVHD
18. study of associations between serum albumin levels and aGVHD
19. Study of Correlation between uric acid level and aGVHD
20. Evaluation of CD161+ T cells as predictive biomarker of aGVHD
21. Study of association between methylation changes and aGvHD
22. Assessment of miR-194 and CXCL3 gene expression for prediction of acute GVHD after allogeneic HSCT
23. Assessment of fecal calprotectin as predictive biomarker of intestinal GVHD
23. Assessment of miR-518f and EGFR1 gene expression for prediction of acute GVHD after allogeneic HSCT
25. The study of association between iNKT cells in PBSC grafts with aGVHD after allogeneic HSCT
26. The study of Th17-prone CD146+CC5+ cells as early predictive biomarkers of aGvHD
27. High risk HLA allels for severe aGVHD in allogeneic bone marrow transplantation
28. The study of association between CD30 with aGVHD after allogeneic HSCT
29. The study of association between ferritin and aGVHD after allergenic HSCT.
30. Cytokine expression profile

Powered by